LCI Industries (NYSE:LCII) Receives $156.00 Consensus PT from Analysts
LCI Industries (NYSE:LCII – Get Free Report) has been given an average rating of “Hold” by the nine ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation to […]
Albertsons Companies, Inc. (NYSE:ACI) Receives $21.58 Consensus PT from Analysts
Shares of Albertsons Companies, Inc. (NYSE:ACI – Get Free Report) have earned a consensus rating of “Hold” from the sixteen ratings firms that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and nine have assigned a buy recommendation to the […]
AMC Entertainment Holdings, Inc. (NYSE:AMC) Receives $2.32 Consensus PT from Analysts
Shares of AMC Entertainment Holdings, Inc. (NYSE:AMC – Get Free Report) have been given an average recommendation of “Reduce” by the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has assigned a buy […]
Boise Cascade, L.L.C. (NYSE:BCC) Receives $105.67 Consensus PT from Analysts
Shares of Boise Cascade, L.L.C. (NYSE:BCC – Get Free Report) have received an average recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month price target among […]
Bioventus Inc. (NASDAQ:BVS) Receives $14.00 Consensus PT from Analysts
Shares of Bioventus Inc. (NASDAQ:BVS – Get Free Report) have been assigned an average rating of “Buy” from the five ratings firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to […]
Arcus Biosciences, Inc. (NYSE:RCUS) Receives $30.20 Consensus PT from Analysts
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve research firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has […]
last updated on 15 Apr 10:49